Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Haraoui LP"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-6 z 6
    Tytuł:
    Antimicrobial-Resistant Infections after Turkey/Syria Earthquakes, 2023.
    Autorzy:
    Rizk A
    Abou Fayad A
    Haraoui LP
    Pokaż więcej
    Źródło:
    Emerging infectious diseases [Emerg Infect Dis] 2023 Jun; Vol. 29 (6), pp. 1273-1275. Date of Electronic Publication: 2023 Apr 17.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Earthquakes*
    Anti-Infective Agents*
    Humans ; Turkey/epidemiology ; Syria/epidemiology ; Hospitals ; Anti-Bacterial Agents/pharmacology ; Drug Resistance, Bacterial
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    VANCOmycin dose adjustments comparing trough levels to the ratio of the area under de curve to the minimum inhibitory concentration method using a BAYESian approach: A feasibility study.
    Autorzy:
    Bilodeau V; Department of Pharmacy, Centre intégré de santé et de services sociaux Montérégie-Centre, Greenfield Park, Quebec, Canada.; Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
    Huot J; Department of Pharmacy, Centre intégré de santé et de services sociaux Montérégie-Centre, Greenfield Park, Quebec, Canada.; Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
    Perreault C; Department of Pharmacy, Centre intégré de santé et de services sociaux Montérégie-Centre, Greenfield Park, Quebec, Canada.; Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
    Haraoui LP; Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Quebec, Canada.
    Delorme C; Department of Pharmacy, Centre intégré de santé et de services sociaux Montérégie-Centre, Greenfield Park, Quebec, Canada.
    Poudrette J; Department of Pharmacy, Centre intégré de santé et de services sociaux Montérégie-Centre, Greenfield Park, Quebec, Canada.
    Marsot A; Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada.
    Crevier B; Department of Pharmacy, Centre intégré de santé et de services sociaux Montérégie-Centre, Greenfield Park, Quebec, Canada.
    Pokaż więcej
    Źródło:
    Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] 2022 Dec; Vol. 47 (12), pp. 2335-2344. Date of Electronic Publication: 2022 Dec 02.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Vancomycin*
    Anti-Bacterial Agents*
    Humans ; Feasibility Studies ; Bayes Theorem ; Prospective Studies ; Area Under Curve ; Microbial Sensitivity Tests ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Management and clinical outcomes of Lyme disease in acute care facilities in 2 endemic regions of Quebec, Canada: a multicentre retrospective cohort study.
    Autorzy:
    Musonera JB; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Valiquette L; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Baron G; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Milord F; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Marcoux D; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Thivierge K; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Bedard-Dallaire S; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Pelletier AA; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Lachance R; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Bourget J; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Simard C; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Cantin E; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Abbasi F; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Haraoui LP; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que.
    Carignan A; Department of Microbiology and Infectious Diseases (Musonera, Valiquette, Marcoux, Bedard-Dallaire, Pelletier, Haraoui, Carignan), Department of Community Health Sciences (Baron, Milord) and Faculté de médecine et des Sciences de la santé (Lachance, Bourget, Cantin, Abbasi), Université de Sherbrooke, Sherbrooke, Que.; Laboratoire de santé publique du Québec (Thivierge), Montréal, Que.; Université Laval (Simard), Québec, Que. .
    Pokaż więcej
    Źródło:
    CMAJ open [CMAJ Open] 2022 Jun 28; Vol. 10 (2), pp. E570-E576. Date of Electronic Publication: 2022 Jun 28 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Lyme Disease*/diagnosis
    Lyme Disease*/drug therapy
    Lyme Disease*/epidemiology
    Post-Lyme Disease Syndrome*
    Adolescent ; Adult ; Aged ; Aged, 80 and over ; Canada ; Child ; Child, Preschool ; Cohort Studies ; Humans ; Middle Aged ; Prospective Studies ; Quebec/epidemiology ; Retrospective Studies ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Oral Sex following Abortion: Case Report of a Sexually Transmitted Infection of Group A Streptococcus Causing Peritonitis.
    Autorzy:
    Chan KL; Department of Gynecology, Charles-LeMoyne Hospital, Greenfield Park, Canada.
    Haraoui LP; Department of Microbiology, Université de Sherbrooke, Canada.
    Demczuk W; National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
    Domingo MC; Institut National de Santé Publique du Québec, Laboratoire de Santé Publique du Québec, Canada.
    Bergeron E; Department of Surgery, Charles-LeMoyne Hospital, Greenfield Park, Canada.
    Pokaż więcej
    Źródło:
    Case reports in surgery [Case Rep Surg] 2022 Mar 31; Vol. 2022, pp. 1362255. Date of Electronic Publication: 2022 Mar 31 (Print Publication: 2022).
    Typ publikacji:
    Case Reports
    Raport
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    An unequivocal superbug: PDR Klebsiella pneumoniae with an arsenal of resistance and virulence factor genes.
    Autorzy:
    Sleiman A; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
    Awada B; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
    Mocadie M; Division of Infectious Diseases, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
    Sherri N; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
    Haraoui LP; Department of Microbiology and Infectious Diseases, University of Sherbrooke, Sherbrooke, QC, Canada.
    Baby V; Department of Microbiology and Infectious Diseases, University of Sherbrooke, Sherbrooke, QC, Canada.
    Araj GF; Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
    Kanj SS; Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
    Rizk N; Center for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
    Matar GM; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
    Abou Fayad AG; Department of Experimental Pathology, Immunology and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. .
    Pokaż więcej
    Źródło:
    Journal of infection in developing countries [J Infect Dev Ctries] 2021 Mar 31; Vol. 15 (3), pp. 404-414. Date of Electronic Publication: 2021 Mar 31.
    Typ publikacji:
    Case Reports; Journal Article; Review
    MeSH Terms:
    Anti-Bacterial Agents/*pharmacology
    Drug Resistance, Multiple, Bacterial/*genetics
    Klebsiella pneumoniae/*drug effects
    Anti-Bacterial Agents/therapeutic use ; Catheter-Related Infections/etiology ; Global Health ; Humans ; Klebsiella Infections/epidemiology ; Klebsiella pneumoniae/genetics ; Male ; Virulence Factors ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-6 z 6

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies